Blossom Health宣布获得 2000万美元，将人工智能操作系统推广至全国精神科医生和患者手中

NEW YORK

纽约

,

，

March 26, 2026

2026年3月26日

/PRNewswire/ --

/PRNewswire/ --

Blossom Health

花朵健康

, the leading all-in-one AI operating system for psychiatry, today announced $20M in funding across a Series A and Seed round. Headline led the Series A with Mathias Schilling, Co-Founder and Managing Partner of Headline, joining the board. Returning investors Village Global and TA Ventures also participated in the Series A alongside new investors Operator Partners and Correlation Ventures.

，领先的一体化精神病学人工智能操作系统，今天宣布在A轮融资和种子轮融资中共获得2000万美元。Headline领投了A轮融资，Headline的联合创始人兼管理合伙人马蒂亚斯·席林加入董事会。回归的投资者Village Global和TA Ventures也参与了A轮融资，新投资者Operator Partners和Correlation Ventures也加入了此轮融资。

A number of angel investors were involved as well, including the founders of General Catalyst, Flatiron Health, Sword Health, Fay, Elemy, Zip, Blank Street, Assured, Bridge, Birches Health, and Enzo Health..

一些天使投资人也参与其中，包括General Catalyst、Flatiron Health、Sword Health、Fay、Elemy、Zip、Blank Street、Assured、Bridge、Birches Health和Enzo Health的创始人。

Continue Reading

继续阅读

John Zhao, Founder and CEO of Blossom Health

赵约翰，Blossom Health创始人兼首席执行官

'Mental Health is the singular most important public health crisis in America,' said John Zhao, Founder and CEO of Blossom Health. 'Tens of millions of Americans are suffering because of an acute shortage in psychiatric care. By productizing AI to supercharge psychiatrists, Blossom is finally making psychiatry affordable and attainable for every American in need.'.

“心理健康是美国最重要的公共卫生危机，”Blossom Health创始人兼首席执行官赵约翰表示。“由于精神科护理的严重短缺，数以千万计的美国人正在遭受痛苦。通过将人工智能产品化以增强精神科医生的能力，Blossom终于让每个有需要的美国人都能负担得起并获得精神科治疗。”

Blossom Health's AI operating system functions as the singular substrate for psychiatry, upon which autonomous agents and clinical copilots interact in symphony with psychiatrists. By orchestrating interactions between psychiatrists, patients, payors, pharmacists, referralists, and other participants in the healthcare ecosystem, Blossom ensures superior care delivery, at scale..

Blossom Health的AI操作系统作为精神病学的单一基底，自主代理和临床副驾驶在此基础上与精神科医生协同交互。通过协调精神科医生、患者、支付方、药剂师、转诊人员及其他医疗生态系统参与者的互动，Blossom确保在大规模范围内提供卓越的医疗服务。

Blossom clinical copilots augment the medical decision-making of psychiatrists, assisting them in making the right diagnoses, crafting the right treatment plan, and selecting the right medications. With thousands of patients already treated, Blossom has demonstrated an ability to stabilize and improve mental health outcomes, halting and reversing patient progression towards higher-acuity care..

Blossom临床辅助系统增强了精神科医生的医疗决策能力，帮助他们做出正确的诊断、制定合适的治疗计划并选择适当的药物。通过已经治疗的数千名患者，Blossom展示了其稳定和改善心理健康结果的能力，阻止并逆转患者向更高强度护理发展的趋势。

Blossom's AI agents also remove the administrative burden and complexity of running a medical practice for psychiatrists. By surrounding clinicians with agentic billers, schedulers, receptionists, care coordinations, scribes, medical assistants, and more - Blossom empowers psychiatrists to achieve their best..

Blossom的AI代理还减轻了精神科医生经营医疗实践的行政负担和复杂性。通过为临床医生配备代理账单员、调度员、接待员、护理协调员、记录员、医疗助理等，Blossom助力精神科医生实现最佳表现。

With the Series A funding, Blossom will expand its state coverage, contract with national and regional health insurance payors, onboard more providers, as well as invest in R&D to accelerate its frontier applied-AI technology.

通过A轮融资，Blossom将扩大其州覆盖范围，与国家和区域健康保险支付方签订合同，引入更多供应商，并投资于研发以加速其前沿应用人工智能技术。

'Blossom is addressing one of the most urgent and consequential challenges in modern healthcare with extraordinary focus and technological depth,' said Mathias Schilling, Co-Founder and Managing Partner of Headline. 'Their AI operating system is not just improving access to psychiatric care-it's fundamentally redefining how clinicians practice and how patients heal.

“Blossom 正以非凡的专注和技术深度应对现代医疗保健中最紧迫且影响深远的挑战之一，”Headline 的联合创始人兼管理合伙人马蒂亚斯·施林说。“他们的 AI 操作系统不仅改善了精神病治疗的可及性，更从根本上重新定义了临床医生的实践方式和患者的康复过程。”

We believe Blossom has the potential to become the technological backbone of modern mental health, bridging the gap between overwhelming demand and limited clinical supply.'.

我们相信Blossom有潜力成为现代心理健康的技术支柱，弥合巨大的需求与有限的临床资源之间的差距。

For patients looking to access care through Blossom, click

通过Blossom寻求护理的患者，请点击

here

这里

. For psychiatric clinicians looking to join Blossom, click

想要加入Blossom的精神科临床医生，请点击

here

这里

. For other clinicians looking to refer patients to Blossom, click

。对于其他希望将患者转诊至Blossom的临床医生，请点击

here

这里

. To get in touch with the Blossom team, please email

要与Blossom团队联系，请发送电子邮件至

[email protected]

电子邮件地址

.

。

About Blossom

关于Blossom

Blossom is the AI operating system for psychiatry, the all-in-one partner of choice to psychiatrists and psychiatric nurse practitioners. Its tools are already used by hundreds of clinicians treating thousands of patients across multiple states, improving health outcomes and eliminating administrative overhead.

Blossom 是精神病学的人工智能操作系统，是精神科医生和精神科护士从业者的首选一体化伙伴。其工具已被数百名临床医生使用，治疗跨多个州的数千名患者，改善健康结果并消除行政负担。

Blossom's in-network coverage with all major commercial insurers, including Optum UnitedHealthcare, Aetna, Cigna Evernorth, and Blue Cross Blue Shield, means $22 average copays, putting psychiatric care within reach for millions of patients. And with most patients seen in under 48 hours, oftentimes same-day, Blossom offers unparalleled timeliness in access to care..

Blossom与所有主要商业保险公司（包括Optum UnitedHealthcare、Aetna、Cigna Evernorth和Blue Cross Blue Shield）的网络内覆盖意味着平均22美元的共付额，使数百万患者能够负担得起精神科护理。并且，大多数患者在48小时内就能得到诊治，很多时候甚至是当天，Blossom在获得护理的及时性方面提供了无与伦比的服务。

About Headline

关于标题

Founded in 1998, Headline is a global venture capital firm that partners with fast-growing technology companies to help make their success global. With more than $4 billion in assets under management, Headline invests through a network of regionally focused early-stage funds across the U.S., Europe, Asia, and Latin America, as well as its Global Growth Fund, which backs companies from Series B and beyond.

Headline 成立于1998年，是一家全球风险投资公司，与快速发展的技术公司合作，帮助它们取得全球性的成功。Headline 管理的资产超过40亿美元，通过遍布美国、欧洲、亚洲和拉丁美洲的区域性早期基金网络进行投资，同时还拥有其全球增长基金，支持从B轮及以后阶段的公司。

The size and locations of these funds allow the firm to see local trends up close, meet winning founders, and lead rounds at every stage. Among the 300+ investments globally, Headline's portfolio includes Acorns, AppFolio, ANGI (FKA Angie's List), Brite Payments, Bumble, Fetch, Gopuff, Grüns, Honeycomb, LucidLink, Mistral AI, Monta, NGINX, Owner, Raisin, Sonos, Segment, SEMrush, and Staffbase..

这些基金的规模和地理位置使公司能够近距离观察当地趋势、结识成功的创始人，并在各个阶段主导投资轮次。在全球300多项投资中，Headline的投资组合包括Acorns、AppFolio、ANGI（前身为Angie's List）、Brite Payments、Bumble、Fetch、Gopuff、Grüns、Honeycomb、LucidLink、Mistral AI、Monta、NGINX、Owner、Raisin、Sonos、Segment、SEMrush和Staffbase。

Media Contact

媒体联系人

Kelsey Cullen, KCPR

凯尔西·卡伦，KCPR

[email protected]

电子邮件地址

650.438.1063

650.438.1063

SOURCE Blossom Health

来源：Blossom Health

21

21

%

%

more press release views with

更多新闻稿浏览量与

Request a Demo

请求演示